Solesence, Inc. (SLSN)
NASDAQ: SLSN · Real-Time Price · USD
1.010
0.00 (0.00%)
At close: Mar 9, 2026, 4:00 PM EDT
1.000
-0.010 (-0.99%)
After-hours: Mar 9, 2026, 4:08 PM EDT

Solesence Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
0.431.411.722.190.660.96
Cash & Short-Term Investments
0.431.411.722.190.660.96
Cash Growth
-69.55%-18.18%-21.23%232.72%-31.35%-19.85%
Accounts Receivable
9.714.873.474.733.942.93
Inventory
18.8720.2710.038.846.14.34
Other Current Assets
3.792.81.080.870.910.61
Total Current Assets
32.7929.3516.316.6311.68.84
Net Property, Plant & Equipment
21.220.6516.5816.9316.794.7
Other Long-Term Assets
-000.010.010.01
Total Assets
53.995032.8833.5628.3913.54
Accounts Payable
4.839.096.266.363.572.13
Accrued Expenses
5.34.850.871.020.950.48
Short-Term Debt
5.32-2.814.281.352.66
Current Portion of Long-Term Debt
-52--0.5
Current Portion of Leases
1.221.261.3-0.690.61
Unearned Revenue
1.25.572.352.170.780.41
Total Current Liabilities
17.8625.7715.5913.847.346.78
Long-Term Debt
10.5-6412.05
Long-Term Leases
8.149.049.159.8211.711.76
Other Long-Term Liabilities
0.250.250.240.250.880.21
Total Long-Term Liabilities
18.99.2815.3914.0713.594.02
Total Liabilities
36.7635.0630.9827.9120.9310.81
Common Stock
0.710.70.50.490.490.38
Additional Paid-in Capital
115.32114.67106.07105.23104.42102.12
Retained Earnings
-98.8-100.43-104.66-100.07-97.45-99.77
Shareholders' Equity
17.2314.951.95.657.472.73
Total Liabilities & Equity
53.995032.8833.5628.3913.54
Total Debt
25.1815.321.2618.1114.757.57
Net Cash (Debt)
-24.76-13.89-19.54-15.92-14.09-6.62
Net Cash Per Share
-0.35-0.21-0.39-0.32-0.28-0.17
Book Value
17.2314.951.95.657.472.73
Book Value Per Share
0.240.230.040.120.150.07
Tangible Book Value
17.2314.951.95.657.472.73
Tangible Book Value Per Share
0.240.230.040.120.150.07
Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q